Dextech Medical AB reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was SEK 0.034 million compared to SEK 0.117 million a year ago. Net loss was SEK 1.14 million compared to SEK 1.55 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.1 a year ago.
For the six months, sales was SEK 0.077 million compared to SEK 0.237 million a year ago. Net loss was SEK 2.08 million compared to SEK 3.09 million a year ago. Basic loss per share from continuing operations was SEK 0.14 compared to SEK 0.21 a year ago.